Navigation Links
MEI Pharma Announces Pricing of Public Offering of Common Stock
Date:10/25/2013

calling (415) 364-2500, or from Cowen and Company, LLC, c/o Broadridge Financial Services, 1155 Long Island Avenue, Edgewood, New York 11717, Attention: Prospectus Department, or by calling (631) 274-2806, or by faxing (631) 254-7140. An electronic copy of the prospectus supplement and accompanying base prospectus relating to the offering will also be available on the website of the SEC at www.sec.gov.

This release does not constitute an offer to sell, or the solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

About MEI Pharma

MEI Pharma, Inc. (Nasdaq: MEIP) is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer. The Company's lead drug candidate is Pracinostat, a potential best-in-class, oral HDAC inhibitor being developed for advanced hematologic diseases, such as myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). The Company initiated a randomized, placebo-controlled Phase II trial of Pracinostat in combination with Vidaza (azacitidine) in patients with previously untreated MDS in June 2013. An open-label Phase II trial of Pracinostat in combination with Vidaza in elderly patients with AML who are unsuitable for intensive chemotherapy is expected to initiate in the fall of 2013. MEI Pharma is also developing ME-344, a mitochondrial inhibitor derived from its isoflavone-based technology platform. Results from a first-in-human, single-agent clinical study of ME-344 in patients with refractory solid tumors were presented in October 2013. In September 2013, the Company further expanded its pipeline of drug candidates with
'/>"/>

SOURCE MEI Pharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
3. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
4. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
5. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
6. Academy of Managed Care Pharmacy (AMCP) Installs 2012-2013 Board of Directors
7. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
8. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
9. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
10. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
11. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... , May 28, 2015  Freedom Meditech, Inc., ... of chronic diseases from current blood-based standards to early ... raised $4.8 million in a Series C financing. The ... of $14 million since founded. The company has also ... officer and a member of the company,s board of ...
(Date:5/28/2015)... , May 28, 2015   Clementia ... commenced enrollment in the second part (Part B) ... fibrodysplasia ossificans progressiva (FOP), a rare, severely disabling ... soft tissue swelling (flare-ups) that result in the ... tendons and ligaments. The multi-center, ...
(Date:5/28/2015)... 2015  Caris Life Sciences®, a leading biotechnology ... medicine, today announced the presentation of data from ... of Caris Molecular Intelligence®, the company,s panomic comprehensive ... resistance and pathway alterations in solid tumors. The ... at the annual meeting of the American Society ...
Breaking Medicine Technology:Freedom Meditech Raises $4.8 Million and Appoints John Gerace as Chief Executive Officer 2Freedom Meditech Raises $4.8 Million and Appoints John Gerace as Chief Executive Officer 3Freedom Meditech Raises $4.8 Million and Appoints John Gerace as Chief Executive Officer 4Clementia Advances Natural History Study of Patients with Fibrodysplasia Ossificans Progressiva 2Clementia Advances Natural History Study of Patients with Fibrodysplasia Ossificans Progressiva 3Caris Life Sciences Presents Large Cohort Biomarker Analyses that Characterizes Drug Resistances and Pathway Aberrations to Inform Targeted Anticancer Treatment Strategies 2Caris Life Sciences Presents Large Cohort Biomarker Analyses that Characterizes Drug Resistances and Pathway Aberrations to Inform Targeted Anticancer Treatment Strategies 3Caris Life Sciences Presents Large Cohort Biomarker Analyses that Characterizes Drug Resistances and Pathway Aberrations to Inform Targeted Anticancer Treatment Strategies 4Caris Life Sciences Presents Large Cohort Biomarker Analyses that Characterizes Drug Resistances and Pathway Aberrations to Inform Targeted Anticancer Treatment Strategies 5
...  ISPE, the International Society for Pharmaceutical Engineering, today announced ... CEO, effective 1 January 2012. Berg ... growth and relationship-building, having served as executive director/CEO of ... as the founder and owner of three small businesses ...
... 3, 2012  Cutera, Inc. (NASDAQ: CUTR ) ... announced that the companies have entered into a binding ... global aesthetic business for approximately $5.1 million. ... global aesthetic market, with IRIDEX, strength in vascular treatments, ...
Cached Medicine Technology:ISPE Announces Nancy Berg as New CEO and President Succeeding Bob Best Effective 1 January 2Cutera and IRIDEX Announce Acquisition of IRIDEX' Aesthetic Business Unit 2Cutera and IRIDEX Announce Acquisition of IRIDEX' Aesthetic Business Unit 3Cutera and IRIDEX Announce Acquisition of IRIDEX' Aesthetic Business Unit 4
(Date:5/28/2015)... Atlanta-based Thrive Senior Living has announced this ... on an innovative new Assisted Living community in southeast ... in a unique, resort-like environment, Thrive at Jones Farm ... hospitality to create a distinctive experience for a new ... feature luxuriously appointed resident apartments, a spa, beauty salon, ...
(Date:5/28/2015)... Peggy J. Lynam, PT, DPT, NCS from New ... Therapy Association House of Delegates for the New York Physical ... This will be her second term. The Chief ... principle spokesperson for the Chapter delegation and presides over any ... Assembly may direct the Chief Delegate to present matters to ...
(Date:5/28/2015)... The second episode of “Extreme Weight Loss” ... a need to transform their lives. Josh (29 years old) ... to deal with the death of his father. Kelli (26 ... City, MO, who went into depression after her playing career ... be featured in one episode of “Extreme Weight Loss” on ...
(Date:5/27/2015)... and volume loss in the skin have met its ... is excited to introduce a custom menu of non-invasive ... surgical intervention, and without downtime. , “We now use ... that can lift skin using focused ultrasound, and combine ... lifting formula than its predecessor Radiesse, to visibly and ...
(Date:5/27/2015)... Cincinnati, Ohio (PRWEB) May 28, 2015 ... to an informational Open House May 30 from noon-2p.m. ... to learn about how caregivers can offer full-time assistance ... are approved through a comprehensive survey process conducted by ... a personal residence as a medical foster home, the ...
Breaking Medicine News(10 mins):Health News:Thrive Announces Innovative New Senior Living Community in Huntsville, AL 2Health News:“Extreme Weight Loss”: Josh and Kelli’s Journeys Begin at the University of Colorado Anschutz Health and Wellness Center 2Health News:“Extreme Weight Loss”: Josh and Kelli’s Journeys Begin at the University of Colorado Anschutz Health and Wellness Center 3Health News:Skin Expert Holly CaSaroll Announces New Cutting Edge Results with RadiessePlus Filler Available at Detroit Skin and Wellness Clinic 2
... have highlighted the beneficial effect of cardiac resynchronisation ... reduction of mortality, and CRT is now recommended ... the treatment and prevention of heart failure.(1), Clinical ... and their results are not always applicable to ...
... 17 (HealthDay News) -- The busy holiday season may disrupt ... it is especially important to remember to look after your ... people to consume sugary treats and drink alcoholic beverages more ... General Dentistry, said in an academy news release. "Additionally, ...
... Dec. 16 (HealthDay News) -- First responders at the World ... rate of the general U.S. population, new research shows. ... American Journal of Industrial Medicine , researchers found this ... their exposure to the toxic dust created when the towers ...
... (HealthDay News) -- Modern humans -- Homo sapiens ... Neanderthal cousins, which may be one reason why one ... Brain size is the same in both species, but differences ... may be linked to behavior and cognition, which includes skills ...
... Institute has received a three-year, $6 million grant from ... a model for strengthening national public health institutes (NPHIs) ... foundation grant to the International Association of National Public ... or substantially increased capacity at NPHIs in 10 ...
... By Jenifer Goodwin HealthDay Reporter , THURSDAY, Dec. ... on parent-child ties, with parents who were under financial strain ... kids saying they were less likely to act with generosity, ... and Brigham Young University analyzed data from a survey done ...
Cached Medicine News:Health News:The benefits of cardiac resynchronisation therapy in heart failure 2Health News:The benefits of cardiac resynchronisation therapy in heart failure 3Health News:Dentist Gives Advice to Keep Holiday Smiles Bright 2Health News:WTC First Responders More Likely to Have Asthma: Study 2Health News:Sense of Smell Helped Separate Humans From Neanderthals 2Health News:Emory and US CDC partner to continue building global public health network with $6 million grant 2Health News:Emory and US CDC partner to continue building global public health network with $6 million grant 3Health News:Emory and US CDC partner to continue building global public health network with $6 million grant 4Health News:Recession Hurt Parent-Child Ties, Survey Finds 2Health News:Recession Hurt Parent-Child Ties, Survey Finds 3
... system includes a cruciate sparing version ... mates with both resurfacing and inset ... repeatable kinematics and fit with tibial ... wear. Constant cutting guide peg locations ...
... The TC-PLUS solution tricompartmental total knee ... with knee arthroplasty. State-of-the-art design and manufacturing ... achieve optimum biomechanical function as well as ... polyethylene tibial insert to keep wear to ...
The Foundation PS knee offers a femoral option and tibial insert which provides a specially designed cam action that engages at 60 degrees of flexion to induce a smooth stable femoral roll-back motio...
... Natural Knee design includes several ... CSTi porous coating option for ... a unique bone preserving posterior ... groove to maximize range of ...
Medicine Products: